Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$26.13 - $33.94 $1.35 Million - $1.76 Million
-51,768 Reduced 79.77%
13,130 $378,000
Q3 2023

Oct 19, 2023

BUY
$32.09 - $37.51 $72,619 - $84,885
2,263 Added 3.61%
64,898 $2.15 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $43,055 - $49,813
1,192 Added 1.94%
62,635 $2.3 Million
Q1 2023

May 02, 2023

BUY
$39.39 - $51.28 $272,263 - $354,447
6,912 Added 12.68%
61,443 $2.51 Million
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $258,891 - $337,954
6,201 Added 12.83%
54,531 $0
Q3 2022

Nov 01, 2022

BUY
$43.76 - $53.42 $407,318 - $497,233
9,308 Added 23.85%
48,330 $2.12 Million
Q2 2022

Jul 26, 2022

BUY
$46.53 - $55.17 $204,127 - $242,030
4,387 Added 12.67%
39,022 $2.05 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $363,163 - $450,005
7,938 Added 29.73%
34,635 $1.79 Million
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $168,420 - $249,655
4,076 Added 18.02%
26,697 $1.58 Million
Q3 2021

Oct 22, 2021

BUY
$39.25 - $50.42 $50,828 - $65,293
1,295 Added 6.07%
22,621 $972,000
Q2 2021

Jul 26, 2021

BUY
$35.91 - $40.68 $133,333 - $151,044
3,713 Added 21.08%
21,326 $835,000
Q1 2021

Apr 30, 2021

BUY
$33.49 - $37.77 $226,827 - $255,816
6,773 Added 62.48%
17,613 $638,000
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $27,847 - $35,409
832 Added 8.31%
10,840 $399,000
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $44,323 - $52,001
1,396 Added 16.21%
10,008 $367,000
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $32,860 - $39,865
1,091 Added 14.51%
8,612 $281,000
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $58,276 - $83,264
2,156 Added 40.19%
7,521 $243,000
Q4 2019

Jan 16, 2020

BUY
$32.92 - $37.36 $176,615 - $200,436
5,365 New
5,365 $210,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lineweaver Wealth Advisors, LLC Portfolio

Follow Lineweaver Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lineweaver Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lineweaver Wealth Advisors, LLC with notifications on news.